Pesquisa | Portal de Pesquisa da BVS

1.

Clopidogrel resistance: pharmacokinetic or pharmacogenetic?

Ford, Neville F.

J Clin Pharmacol ; 49(5): 506-12, 2009 May.

Artigo em Inglês | MEDLINE | ID: mdl-19246723

2.

The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway.

Ford, Neville F.

J Clin Pharmacol ; 56(12): 1474-1483, 2016 12.

Artigo em Inglês | MEDLINE | ID: mdl-27196064

3.

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Hennekens, Charles H; Sacks, Frank M; Tonkin, Andrew; Jukema, J Wouter; Byington, Robert P; Pitt, Bertram; Berry, Donald A; Berry, Scott M; Ford, Neville F; Walker, Andrew J; Natarajan, Kannan; Sheng-Lin, Chen; Fiedorek, Frederick T; Belder, Rene.

Arch Intern Med ; 164(1): 40-4, 2004 Jan 12.

Artigo em Inglês | MEDLINE | ID: mdl-14718320

4.

Clopidogrel, CYP2C19, and a Black Box.

Ford, Neville F; Taubert, Dirk.

J Clin Pharmacol ; 53(3): 241-8, 2013 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-23381692

5.

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.

Bauer, Tim; Bouman, Heleen J; van Werkum, Jochem W; Ford, Neville F; ten Berg, Jurriën M; Taubert, Dirk.

BMJ ; 343: d4588, 2011 Aug 04.

Artigo em Inglês | MEDLINE | ID: mdl-21816733

6.

Clopidogrel and Genotyping.

Ford, Neville F.

J Invasive Cardiol ; 27(8): E173-4, 2015 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-26232022

7.

Clopidogrel: what is a cardiologist to do?

Ford, Neville F.

J Clin Pharmacol ; 54(8): 881-3, 2014 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-24824921

8.

Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.

Dhaun, Neeraj; Strachan, Fiona E; Newby, David E; Johnston, Neil R; Ford, Neville F; Hammett, Janis L; Palmisano, Maria; Webb, David J.

Br J Clin Pharmacol ; 60(6): 611-22, 2005 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-16305585

Portal de Pesquisa da BVS

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Clopidogrel resistance: pharmacokinetic or pharmacogenetic?

The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway.

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Clopidogrel, CYP2C19, and a Black Box.

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.

Clopidogrel and Genotyping.

Clopidogrel: what is a cardiologist to do?

Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.